![1]()
News
Anakinra improved survival in hospitalized COVID-19 patients
September 7, 2021
Phase 3 randomized trial showed improved survival and shorter hospital stay in COVID-19 patients who were given anakinra, compared with those given a placebo.
![1]()
Opinion
Addressing vaccine hesitancy with patients
September 7, 2021
Why are some patients hesitant about receiving a lifesaving vaccine?
News
Health care–associated infections spiked in 2020 in U.S. hospitals
September 7, 2021
This is the first increase in health care–associated infections since 2015.
News
Beta-blocker reduces lung inflammation in critical COVID-19
September 7, 2021
Metoprolol administration also resulted in better oxygenation and fewer days on intensive mechanical ventilation and in the ICU, compared with no treatment.
News
‘Lopioid protocol’ – low-dose opioids – proposed for fracture surgery
September 3, 2021
“Managing narcotics postoperatively can be challenging due to the fact that many people come into these fractures with a history of narcotic use.”
![1]()
News
Hospitalists address patient experience during the pandemic
September 3, 2021
“A lot of the care hospitalists provide involves touch, sitting down and looking at the patient eye to eye, on the same level.” says Dr. Minesh Patel.
News
WHO tracking new COVID-19 variant called Mu
September 2, 2021
The World Health Organization is tracking a new COVID-19 variant called Mu, which could be able to evade the immunity provided by the vaccines and prior infections.The variant, also kn...
![1]()
News
High prevalence of Fall Risk–Increasing Drugs in older adults after falls
September 2, 2021
Are we reducing use of Fall Risk–Increasing Drugs (FRIDs) after a fall, and if so, does it alone reduce fall risk?
News
Pfizer starts dosing patients in oral COVID-19 drug trial
September 2, 2021
Pfizer’s mid-to-late-stage trial in 1,140 participants would study the therapy PF-07321332 in combination with a low dose of ritonavir.
News
Breakthrough infections twice as likely to be asymptomatic
September 1, 2021
New research found that of 1.2 million adults who received at least one dose of either the Pfizer, Moderna, or AstraZeneca vaccine, fewer than 0.5% tested positive for COVID-19 14 days after their first dose.
